AI drives decision inputs: In 2025, both big pharma and small pharma use advanced predictive modeling, digital twins, and AI-powered analytics throughout R&D and regulatory processes. This reduces ...

The Trump administration wants countries that receive U.S. health aid to share data with Washington about pathogens that ...

Market opportunities arise from the growing need for modernization and compliance assurance in FDA-regulated industries focusing on data integrity. Emphasizing cloud computing, automation, and mobile ...

To better recognise its potential to address the challenge of white space in clinical trials, it helps to first understand ...

Ultimately, Khan emphasized that protecting PHI requires more than compliance checkboxes—it demands a continuous, structured ...

Portfolio Receipts growth of 11% to $814 million; Royalty Receipts growth of 11% Net cash provided by operating activities of $703 million Raised ...

Novo Nordisk India and Emcure Pharma announced a strategic partnership on Monday to launch Poviztra (semaglutide injection 2.4 mg) in India. The collaboration aims to enhance the distribution and ...

Evaluation: Healthcare AI must surpass accuracy metrics to establish clinical validity, safety, and suitability for diverse ...

Market opportunities lie in modernizing software development and validation approaches, emphasizing agility and continuous validation to meet changing needs, while ensuring compliance with FDA ...

Recce Pharmaceuticals Ltd. ( ($AU:RCE) ) just unveiled an update. Recce Pharmaceuticals Ltd presented at their Annual General Meeting in 2025, ...

Wegovy, the blockbuster weight-loss drug launched in June, is set to get cheaper in India. Danish drugmaker Novo Nordisk has ...

The growing number of clinical trials, increasing regulatory complexity, and rapid AI integration in the life sciences sector are driving a radical change in the process of creating and managing ...